Camila Beatriz Barros Araújo

Camila Beatriz Barros Araújo

Auto-generated profile, based on publicly available information

Camila Beatriz Barros Araújo

Department of Pharmacy, Laboratory of Development and Characterization of Pharmaceuticals, State University of Paraíba, Campina Grande, PB, Brazil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2022 in Current Pharmaceutical Analysis
Verified
Journal Article
Closed access
PDF file
JLJoandra Maísa Silva Leite
Joandra Maísa Silva Leite
CACamila Beatriz Barros Araújo
Camila Beatriz Barros Araújo
LALarissa Pereira Alves
Larissa Pereira Alves
MPMilena Raissa Bezerra Pereira
Milena Raissa Bezerra Pereira
GGGabryella Garcia Guedes
Gabryella Garcia Guedes
BDBolívar Ponciano Goulart de Lima Damasceno
Bolívar Ponciano Goulart de Lima Damasceno
Background: Dexamethasone (DEXA) is a potent synthetic corticosteroid derived from the cyclopentanoperhydrophenanthrene nucleus known for its anti-inflammatory and immunosuppressive activities. Due to its therapeutic effects, several analytical methods have been used for its quantitative determination and physicochemical characterization, as well as for the evaluation of pharmacological and toxicological properties. Objective: This review aimed to describe the principles and methods commonly used to identify and quantify DEXA in drug delivery systems and biological samples. The methods herein discussed are high-performance liquid chromatography, nuclear magnetic resonance, x-ray diffraction, Fourier-transform infrared spectroscopy, differential scanning calorimetry, ultravioletvisible spectrophotometry and thin layer chromatography. Conclusion: This review provided a wide variety of analytical methods that can be used for the quantification and identification of drugs, providing scientists with great support during the development of scientific research, as well as ensuring the quality of the manufacturing processes as well as the resulting products. Therefore, the use of such analytical methods has become critical throughout the process of developing pharmaceutical formulations containing DEXA.